Gilead Sciences reported $1000K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
ALKERMES ALKS:US USD 1.69M 1000
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Amgen AMGN:US USD 32.37B 1.03B
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Bristol Myers Squibb BMY:US USD 292M 0
Coherus Biosciences CHRS:US USD 7K 0
Eli Lilly And LLY:US USD 594.1M 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Glaxosmithkline GSK:US GBP 1.5B 136.72M
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Moderna Inc MRNA:US USD 38.7K 500
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 878.25M 11.75M
Ptc Therapeutics PTCT:US USD 71K 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Sangamo Biosciences SGMO:US USD 1.62M 85K
Sarepta Therapeutics SRPT:US USD 9K 0
Teva Pharmaceutical Industries TEVA:US USD 57M 0
United Therapeutics UTHR:US USD 700K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
YTE INCY:US USD 222K 0